Peptide CDMO Market, Global Outlook and Forecast 2022-2028
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
This report contains market size and forecasts of Peptide CDMO in global, including the following market information:
Global Peptide CDMO Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide CDMO Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Peptide CDMO companies in 2021 (%)
The global Peptide CDMO market was valued at 2369.8 million in 2021 and is projected to reach US$ 6106.7 million by 2028, at a CAGR of 14.5% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
APIs and Intermediates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide CDMO include Bachem, PolyPeptide, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript and Xinbang Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide CDMO manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide CDMO Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Peptide CDMO Market Segment Percentages, by Type, 2021 (%)
Global Peptide CDMO Market Segment Percentages, by Application, 2021 (%)
Global Peptide CDMO Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Peptide CDMO revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide CDMO revenues share in global market, 2021 (%)
Key companies Peptide CDMO sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Peptide CDMO sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
This report contains market size and forecasts of Peptide CDMO in global, including the following market information:
Global Peptide CDMO Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide CDMO Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Peptide CDMO companies in 2021 (%)
The global Peptide CDMO market was valued at 2369.8 million in 2021 and is projected to reach US$ 6106.7 million by 2028, at a CAGR of 14.5% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
APIs and Intermediates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide CDMO include Bachem, PolyPeptide, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript and Xinbang Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide CDMO manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide CDMO Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Peptide CDMO Market Segment Percentages, by Type, 2021 (%)
- APIs and Intermediates
- FDF
Global Peptide CDMO Market Segment Percentages, by Application, 2021 (%)
- Commercial
- Academic Research
Global Peptide CDMO Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Peptide CDMO revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide CDMO revenues share in global market, 2021 (%)
Key companies Peptide CDMO sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Peptide CDMO sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bachem
- PolyPeptide
- AmbioPharm
- USV Peptides
- Thermo Fisher
- Bio Basic
- JPT
- Genscript
- Xinbang Pharma
- ScinoPharm
- SN Biopharm
- CBL
- Piramal Pharma
- CordenPharma
- CPC Scientific
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Peptide CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PEPTIDE CDMO OVERALL MARKET SIZE
2.1 Global Peptide CDMO Market Size: 2021 VS 2028
2.2 Global Peptide CDMO Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Peptide CDMO Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Peptide CDMO Players in Global Market
3.2 Top Global Peptide CDMO Companies Ranked by Revenue
3.3 Global Peptide CDMO Revenue by Companies
3.4 Global Peptide CDMO Sales by Companies
3.5 Global Peptide CDMO Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Peptide CDMO Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Peptide CDMO Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide CDMO Players in Global Market
3.8.1 List of Global Tier 1 Peptide CDMO Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide CDMO Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Peptide CDMO Market Size Markets, 2021 & 2028
4.1.2 APIs and Intermediates
4.1.3 FDF
4.2 By Type - Global Peptide CDMO Revenue & Forecasts
4.2.1 By Type - Global Peptide CDMO Revenue, 2017-2022
4.2.2 By Type - Global Peptide CDMO Revenue, 2023-2028
4.2.3 By Type - Global Peptide CDMO Revenue Market Share, 2017-2028
4.3 By Type - Global Peptide CDMO Sales & Forecasts
4.3.1 By Type - Global Peptide CDMO Sales, 2017-2022
4.3.2 By Type - Global Peptide CDMO Sales, 2023-2028
4.3.3 By Type - Global Peptide CDMO Sales Market Share, 2017-2028
4.4 By Type - Global Peptide CDMO Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Peptide CDMO Market Size, 2021 & 2028
5.1.2 Commercial
5.1.3 Academic Research
5.2 By Application - Global Peptide CDMO Revenue & Forecasts
5.2.1 By Application - Global Peptide CDMO Revenue, 2017-2022
5.2.2 By Application - Global Peptide CDMO Revenue, 2023-2028
5.2.3 By Application - Global Peptide CDMO Revenue Market Share, 2017-2028
5.3 By Application - Global Peptide CDMO Sales & Forecasts
5.3.1 By Application - Global Peptide CDMO Sales, 2017-2022
5.3.2 By Application - Global Peptide CDMO Sales, 2023-2028
5.3.3 By Application - Global Peptide CDMO Sales Market Share, 2017-2028
5.4 By Application - Global Peptide CDMO Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Peptide CDMO Market Size, 2021 & 2028
6.2 By Region - Global Peptide CDMO Revenue & Forecasts
6.2.1 By Region - Global Peptide CDMO Revenue, 2017-2022
6.2.2 By Region - Global Peptide CDMO Revenue, 2023-2028
6.2.3 By Region - Global Peptide CDMO Revenue Market Share, 2017-2028
6.3 By Region - Global Peptide CDMO Sales & Forecasts
6.3.1 By Region - Global Peptide CDMO Sales, 2017-2022
6.3.2 By Region - Global Peptide CDMO Sales, 2023-2028
6.3.3 By Region - Global Peptide CDMO Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Peptide CDMO Revenue, 2017-2028
6.4.2 By Country - North America Peptide CDMO Sales, 2017-2028
6.4.3 US Peptide CDMO Market Size, 2017-2028
6.4.4 Canada Peptide CDMO Market Size, 2017-2028
6.4.5 Mexico Peptide CDMO Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Peptide CDMO Revenue, 2017-2028
6.5.2 By Country - Europe Peptide CDMO Sales, 2017-2028
6.5.3 Germany Peptide CDMO Market Size, 2017-2028
6.5.4 France Peptide CDMO Market Size, 2017-2028
6.5.5 U.K. Peptide CDMO Market Size, 2017-2028
6.5.6 Italy Peptide CDMO Market Size, 2017-2028
6.5.7 Russia Peptide CDMO Market Size, 2017-2028
6.5.8 Nordic Countries Peptide CDMO Market Size, 2017-2028
6.5.9 Benelux Peptide CDMO Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Peptide CDMO Revenue, 2017-2028
6.6.2 By Region - Asia Peptide CDMO Sales, 2017-2028
6.6.3 China Peptide CDMO Market Size, 2017-2028
6.6.4 Japan Peptide CDMO Market Size, 2017-2028
6.6.5 South Korea Peptide CDMO Market Size, 2017-2028
6.6.6 Southeast Asia Peptide CDMO Market Size, 2017-2028
6.6.7 India Peptide CDMO Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Peptide CDMO Revenue, 2017-2028
6.7.2 By Country - South America Peptide CDMO Sales, 2017-2028
6.7.3 Brazil Peptide CDMO Market Size, 2017-2028
6.7.4 Argentina Peptide CDMO Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide CDMO Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Peptide CDMO Sales, 2017-2028
6.8.3 Turkey Peptide CDMO Market Size, 2017-2028
6.8.4 Israel Peptide CDMO Market Size, 2017-2028
6.8.5 Saudi Arabia Peptide CDMO Market Size, 2017-2028
6.8.6 UAE Peptide CDMO Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bachem
7.1.1 Bachem Corporate Summary
7.1.2 Bachem Business Overview
7.1.3 Bachem Peptide CDMO Major Product Offerings
7.1.4 Bachem Peptide CDMO Sales and Revenue in Global (2017-2022)
7.1.5 Bachem Key News
7.2 PolyPeptide
7.2.1 PolyPeptide Corporate Summary
7.2.2 PolyPeptide Business Overview
7.2.3 PolyPeptide Peptide CDMO Major Product Offerings
7.2.4 PolyPeptide Peptide CDMO Sales and Revenue in Global (2017-2022)
7.2.5 PolyPeptide Key News
7.3 AmbioPharm
7.3.1 AmbioPharm Corporate Summary
7.3.2 AmbioPharm Business Overview
7.3.3 AmbioPharm Peptide CDMO Major Product Offerings
7.3.4 AmbioPharm Peptide CDMO Sales and Revenue in Global (2017-2022)
7.3.5 AmbioPharm Key News
7.4 USV Peptides
7.4.1 USV Peptides Corporate Summary
7.4.2 USV Peptides Business Overview
7.4.3 USV Peptides Peptide CDMO Major Product Offerings
7.4.4 USV Peptides Peptide CDMO Sales and Revenue in Global (2017-2022)
7.4.5 USV Peptides Key News
7.5 Thermo Fisher
7.5.1 Thermo Fisher Corporate Summary
7.5.2 Thermo Fisher Business Overview
7.5.3 Thermo Fisher Peptide CDMO Major Product Offerings
7.5.4 Thermo Fisher Peptide CDMO Sales and Revenue in Global (2017-2022)
7.5.5 Thermo Fisher Key News
7.6 Bio Basic
7.6.1 Bio Basic Corporate Summary
7.6.2 Bio Basic Business Overview
7.6.3 Bio Basic Peptide CDMO Major Product Offerings
7.6.4 Bio Basic Peptide CDMO Sales and Revenue in Global (2017-2022)
7.6.5 Bio Basic Key News
7.7 JPT
7.7.1 JPT Corporate Summary
7.7.2 JPT Business Overview
7.7.3 JPT Peptide CDMO Major Product Offerings
7.7.4 JPT Peptide CDMO Sales and Revenue in Global (2017-2022)
7.7.5 JPT Key News
7.8 Genscript
7.8.1 Genscript Corporate Summary
7.8.2 Genscript Business Overview
7.8.3 Genscript Peptide CDMO Major Product Offerings
7.8.4 Genscript Peptide CDMO Sales and Revenue in Global (2017-2022)
7.8.5 Genscript Key News
7.9 Xinbang Pharma
7.9.1 Xinbang Pharma Corporate Summary
7.9.2 Xinbang Pharma Business Overview
7.9.3 Xinbang Pharma Peptide CDMO Major Product Offerings
7.9.4 Xinbang Pharma Peptide CDMO Sales and Revenue in Global (2017-2022)
7.9.5 Xinbang Pharma Key News
7.10 ScinoPharm
7.10.1 ScinoPharm Corporate Summary
7.10.2 ScinoPharm Business Overview
7.10.3 ScinoPharm Peptide CDMO Major Product Offerings
7.10.4 ScinoPharm Peptide CDMO Sales and Revenue in Global (2017-2022)
7.10.5 ScinoPharm Key News
7.11 SN Biopharm
7.11.1 SN Biopharm Corporate Summary
7.11.2 SN Biopharm Peptide CDMO Business Overview
7.11.3 SN Biopharm Peptide CDMO Major Product Offerings
7.11.4 SN Biopharm Peptide CDMO Sales and Revenue in Global (2017-2022)
7.11.5 SN Biopharm Key News
7.12 CBL
7.12.1 CBL Corporate Summary
7.12.2 CBL Peptide CDMO Business Overview
7.12.3 CBL Peptide CDMO Major Product Offerings
7.12.4 CBL Peptide CDMO Sales and Revenue in Global (2017-2022)
7.12.5 CBL Key News
7.13 Piramal Pharma
7.13.1 Piramal Pharma Corporate Summary
7.13.2 Piramal Pharma Peptide CDMO Business Overview
7.13.3 Piramal Pharma Peptide CDMO Major Product Offerings
7.13.4 Piramal Pharma Peptide CDMO Sales and Revenue in Global (2017-2022)
7.13.5 Piramal Pharma Key News
7.14 CordenPharma
7.14.1 CordenPharma Corporate Summary
7.14.2 CordenPharma Business Overview
7.14.3 CordenPharma Peptide CDMO Major Product Offerings
7.14.4 CordenPharma Peptide CDMO Sales and Revenue in Global (2017-2022)
7.14.5 CordenPharma Key News
7.15 CPC Scientific
7.15.1 CPC Scientific Corporate Summary
7.15.2 CPC Scientific Business Overview
7.15.3 CPC Scientific Peptide CDMO Major Product Offerings
7.15.4 CPC Scientific Peptide CDMO Sales and Revenue in Global (2017-2022)
7.15.5 CPC Scientific Key News
8 GLOBAL PEPTIDE CDMO PRODUCTION CAPACITY, ANALYSIS
8.1 Global Peptide CDMO Production Capacity, 2017-2028
8.2 Peptide CDMO Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide CDMO Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PEPTIDE CDMO SUPPLY CHAIN ANALYSIS
10.1 Peptide CDMO Industry Value Chain
10.2 Peptide CDMO Upstream Market
10.3 Peptide CDMO Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide CDMO Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Peptide CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PEPTIDE CDMO OVERALL MARKET SIZE
2.1 Global Peptide CDMO Market Size: 2021 VS 2028
2.2 Global Peptide CDMO Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Peptide CDMO Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Peptide CDMO Players in Global Market
3.2 Top Global Peptide CDMO Companies Ranked by Revenue
3.3 Global Peptide CDMO Revenue by Companies
3.4 Global Peptide CDMO Sales by Companies
3.5 Global Peptide CDMO Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Peptide CDMO Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Peptide CDMO Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide CDMO Players in Global Market
3.8.1 List of Global Tier 1 Peptide CDMO Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide CDMO Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Peptide CDMO Market Size Markets, 2021 & 2028
4.1.2 APIs and Intermediates
4.1.3 FDF
4.2 By Type - Global Peptide CDMO Revenue & Forecasts
4.2.1 By Type - Global Peptide CDMO Revenue, 2017-2022
4.2.2 By Type - Global Peptide CDMO Revenue, 2023-2028
4.2.3 By Type - Global Peptide CDMO Revenue Market Share, 2017-2028
4.3 By Type - Global Peptide CDMO Sales & Forecasts
4.3.1 By Type - Global Peptide CDMO Sales, 2017-2022
4.3.2 By Type - Global Peptide CDMO Sales, 2023-2028
4.3.3 By Type - Global Peptide CDMO Sales Market Share, 2017-2028
4.4 By Type - Global Peptide CDMO Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Peptide CDMO Market Size, 2021 & 2028
5.1.2 Commercial
5.1.3 Academic Research
5.2 By Application - Global Peptide CDMO Revenue & Forecasts
5.2.1 By Application - Global Peptide CDMO Revenue, 2017-2022
5.2.2 By Application - Global Peptide CDMO Revenue, 2023-2028
5.2.3 By Application - Global Peptide CDMO Revenue Market Share, 2017-2028
5.3 By Application - Global Peptide CDMO Sales & Forecasts
5.3.1 By Application - Global Peptide CDMO Sales, 2017-2022
5.3.2 By Application - Global Peptide CDMO Sales, 2023-2028
5.3.3 By Application - Global Peptide CDMO Sales Market Share, 2017-2028
5.4 By Application - Global Peptide CDMO Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Peptide CDMO Market Size, 2021 & 2028
6.2 By Region - Global Peptide CDMO Revenue & Forecasts
6.2.1 By Region - Global Peptide CDMO Revenue, 2017-2022
6.2.2 By Region - Global Peptide CDMO Revenue, 2023-2028
6.2.3 By Region - Global Peptide CDMO Revenue Market Share, 2017-2028
6.3 By Region - Global Peptide CDMO Sales & Forecasts
6.3.1 By Region - Global Peptide CDMO Sales, 2017-2022
6.3.2 By Region - Global Peptide CDMO Sales, 2023-2028
6.3.3 By Region - Global Peptide CDMO Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Peptide CDMO Revenue, 2017-2028
6.4.2 By Country - North America Peptide CDMO Sales, 2017-2028
6.4.3 US Peptide CDMO Market Size, 2017-2028
6.4.4 Canada Peptide CDMO Market Size, 2017-2028
6.4.5 Mexico Peptide CDMO Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Peptide CDMO Revenue, 2017-2028
6.5.2 By Country - Europe Peptide CDMO Sales, 2017-2028
6.5.3 Germany Peptide CDMO Market Size, 2017-2028
6.5.4 France Peptide CDMO Market Size, 2017-2028
6.5.5 U.K. Peptide CDMO Market Size, 2017-2028
6.5.6 Italy Peptide CDMO Market Size, 2017-2028
6.5.7 Russia Peptide CDMO Market Size, 2017-2028
6.5.8 Nordic Countries Peptide CDMO Market Size, 2017-2028
6.5.9 Benelux Peptide CDMO Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Peptide CDMO Revenue, 2017-2028
6.6.2 By Region - Asia Peptide CDMO Sales, 2017-2028
6.6.3 China Peptide CDMO Market Size, 2017-2028
6.6.4 Japan Peptide CDMO Market Size, 2017-2028
6.6.5 South Korea Peptide CDMO Market Size, 2017-2028
6.6.6 Southeast Asia Peptide CDMO Market Size, 2017-2028
6.6.7 India Peptide CDMO Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Peptide CDMO Revenue, 2017-2028
6.7.2 By Country - South America Peptide CDMO Sales, 2017-2028
6.7.3 Brazil Peptide CDMO Market Size, 2017-2028
6.7.4 Argentina Peptide CDMO Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide CDMO Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Peptide CDMO Sales, 2017-2028
6.8.3 Turkey Peptide CDMO Market Size, 2017-2028
6.8.4 Israel Peptide CDMO Market Size, 2017-2028
6.8.5 Saudi Arabia Peptide CDMO Market Size, 2017-2028
6.8.6 UAE Peptide CDMO Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bachem
7.1.1 Bachem Corporate Summary
7.1.2 Bachem Business Overview
7.1.3 Bachem Peptide CDMO Major Product Offerings
7.1.4 Bachem Peptide CDMO Sales and Revenue in Global (2017-2022)
7.1.5 Bachem Key News
7.2 PolyPeptide
7.2.1 PolyPeptide Corporate Summary
7.2.2 PolyPeptide Business Overview
7.2.3 PolyPeptide Peptide CDMO Major Product Offerings
7.2.4 PolyPeptide Peptide CDMO Sales and Revenue in Global (2017-2022)
7.2.5 PolyPeptide Key News
7.3 AmbioPharm
7.3.1 AmbioPharm Corporate Summary
7.3.2 AmbioPharm Business Overview
7.3.3 AmbioPharm Peptide CDMO Major Product Offerings
7.3.4 AmbioPharm Peptide CDMO Sales and Revenue in Global (2017-2022)
7.3.5 AmbioPharm Key News
7.4 USV Peptides
7.4.1 USV Peptides Corporate Summary
7.4.2 USV Peptides Business Overview
7.4.3 USV Peptides Peptide CDMO Major Product Offerings
7.4.4 USV Peptides Peptide CDMO Sales and Revenue in Global (2017-2022)
7.4.5 USV Peptides Key News
7.5 Thermo Fisher
7.5.1 Thermo Fisher Corporate Summary
7.5.2 Thermo Fisher Business Overview
7.5.3 Thermo Fisher Peptide CDMO Major Product Offerings
7.5.4 Thermo Fisher Peptide CDMO Sales and Revenue in Global (2017-2022)
7.5.5 Thermo Fisher Key News
7.6 Bio Basic
7.6.1 Bio Basic Corporate Summary
7.6.2 Bio Basic Business Overview
7.6.3 Bio Basic Peptide CDMO Major Product Offerings
7.6.4 Bio Basic Peptide CDMO Sales and Revenue in Global (2017-2022)
7.6.5 Bio Basic Key News
7.7 JPT
7.7.1 JPT Corporate Summary
7.7.2 JPT Business Overview
7.7.3 JPT Peptide CDMO Major Product Offerings
7.7.4 JPT Peptide CDMO Sales and Revenue in Global (2017-2022)
7.7.5 JPT Key News
7.8 Genscript
7.8.1 Genscript Corporate Summary
7.8.2 Genscript Business Overview
7.8.3 Genscript Peptide CDMO Major Product Offerings
7.8.4 Genscript Peptide CDMO Sales and Revenue in Global (2017-2022)
7.8.5 Genscript Key News
7.9 Xinbang Pharma
7.9.1 Xinbang Pharma Corporate Summary
7.9.2 Xinbang Pharma Business Overview
7.9.3 Xinbang Pharma Peptide CDMO Major Product Offerings
7.9.4 Xinbang Pharma Peptide CDMO Sales and Revenue in Global (2017-2022)
7.9.5 Xinbang Pharma Key News
7.10 ScinoPharm
7.10.1 ScinoPharm Corporate Summary
7.10.2 ScinoPharm Business Overview
7.10.3 ScinoPharm Peptide CDMO Major Product Offerings
7.10.4 ScinoPharm Peptide CDMO Sales and Revenue in Global (2017-2022)
7.10.5 ScinoPharm Key News
7.11 SN Biopharm
7.11.1 SN Biopharm Corporate Summary
7.11.2 SN Biopharm Peptide CDMO Business Overview
7.11.3 SN Biopharm Peptide CDMO Major Product Offerings
7.11.4 SN Biopharm Peptide CDMO Sales and Revenue in Global (2017-2022)
7.11.5 SN Biopharm Key News
7.12 CBL
7.12.1 CBL Corporate Summary
7.12.2 CBL Peptide CDMO Business Overview
7.12.3 CBL Peptide CDMO Major Product Offerings
7.12.4 CBL Peptide CDMO Sales and Revenue in Global (2017-2022)
7.12.5 CBL Key News
7.13 Piramal Pharma
7.13.1 Piramal Pharma Corporate Summary
7.13.2 Piramal Pharma Peptide CDMO Business Overview
7.13.3 Piramal Pharma Peptide CDMO Major Product Offerings
7.13.4 Piramal Pharma Peptide CDMO Sales and Revenue in Global (2017-2022)
7.13.5 Piramal Pharma Key News
7.14 CordenPharma
7.14.1 CordenPharma Corporate Summary
7.14.2 CordenPharma Business Overview
7.14.3 CordenPharma Peptide CDMO Major Product Offerings
7.14.4 CordenPharma Peptide CDMO Sales and Revenue in Global (2017-2022)
7.14.5 CordenPharma Key News
7.15 CPC Scientific
7.15.1 CPC Scientific Corporate Summary
7.15.2 CPC Scientific Business Overview
7.15.3 CPC Scientific Peptide CDMO Major Product Offerings
7.15.4 CPC Scientific Peptide CDMO Sales and Revenue in Global (2017-2022)
7.15.5 CPC Scientific Key News
8 GLOBAL PEPTIDE CDMO PRODUCTION CAPACITY, ANALYSIS
8.1 Global Peptide CDMO Production Capacity, 2017-2028
8.2 Peptide CDMO Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide CDMO Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PEPTIDE CDMO SUPPLY CHAIN ANALYSIS
10.1 Peptide CDMO Industry Value Chain
10.2 Peptide CDMO Upstream Market
10.3 Peptide CDMO Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide CDMO Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Peptide CDMO in Global Market
Table 2. Top Peptide CDMO Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Peptide CDMO Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Peptide CDMO Revenue Share by Companies, 2017-2022
Table 5. Global Peptide CDMO Sales by Companies, (Tons), 2017-2022
Table 6. Global Peptide CDMO Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Peptide CDMO Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Peptide CDMO Product Type
Table 9. List of Global Tier 1 Peptide CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Peptide CDMO Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Peptide CDMO Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Peptide CDMO Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Peptide CDMO Sales (Tons), 2017-2022
Table 15. By Type - Global Peptide CDMO Sales (Tons), 2023-2028
Table 16. By Application – Global Peptide CDMO Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Peptide CDMO Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Peptide CDMO Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Peptide CDMO Sales (Tons), 2017-2022
Table 20. By Application - Global Peptide CDMO Sales (Tons), 2023-2028
Table 21. By Region – Global Peptide CDMO Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Peptide CDMO Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Peptide CDMO Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Peptide CDMO Sales (Tons), 2017-2022
Table 25. By Region - Global Peptide CDMO Sales (Tons), 2023-2028
Table 26. By Country - North America Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Peptide CDMO Sales, (Tons), 2017-2022
Table 29. By Country - North America Peptide CDMO Sales, (Tons), 2023-2028
Table 30. By Country - Europe Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Peptide CDMO Sales, (Tons), 2017-2022
Table 33. By Country - Europe Peptide CDMO Sales, (Tons), 2023-2028
Table 34. By Region - Asia Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Peptide CDMO Sales, (Tons), 2017-2022
Table 37. By Region - Asia Peptide CDMO Sales, (Tons), 2023-2028
Table 38. By Country - South America Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Peptide CDMO Sales, (Tons), 2017-2022
Table 41. By Country - South America Peptide CDMO Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Peptide CDMO Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Peptide CDMO Sales, (Tons), 2023-2028
Table 46. Bachem Corporate Summary
Table 47. Bachem Peptide CDMO Product Offerings
Table 48. Bachem Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. PolyPeptide Corporate Summary
Table 50. PolyPeptide Peptide CDMO Product Offerings
Table 51. PolyPeptide Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. AmbioPharm Corporate Summary
Table 53. AmbioPharm Peptide CDMO Product Offerings
Table 54. AmbioPharm Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. USV Peptides Corporate Summary
Table 56. USV Peptides Peptide CDMO Product Offerings
Table 57. USV Peptides Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Thermo Fisher Corporate Summary
Table 59. Thermo Fisher Peptide CDMO Product Offerings
Table 60. Thermo Fisher Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Bio Basic Corporate Summary
Table 62. Bio Basic Peptide CDMO Product Offerings
Table 63. Bio Basic Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. JPT Corporate Summary
Table 65. JPT Peptide CDMO Product Offerings
Table 66. JPT Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Genscript Corporate Summary
Table 68. Genscript Peptide CDMO Product Offerings
Table 69. Genscript Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Xinbang Pharma Corporate Summary
Table 71. Xinbang Pharma Peptide CDMO Product Offerings
Table 72. Xinbang Pharma Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. ScinoPharm Corporate Summary
Table 74. ScinoPharm Peptide CDMO Product Offerings
Table 75. ScinoPharm Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. SN Biopharm Corporate Summary
Table 77. SN Biopharm Peptide CDMO Product Offerings
Table 78. SN Biopharm Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 79. CBL Corporate Summary
Table 80. CBL Peptide CDMO Product Offerings
Table 81. CBL Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 82. Piramal Pharma Corporate Summary
Table 83. Piramal Pharma Peptide CDMO Product Offerings
Table 84. Piramal Pharma Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 85. CordenPharma Corporate Summary
Table 86. CordenPharma Peptide CDMO Product Offerings
Table 87. CordenPharma Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 88. CPC Scientific Corporate Summary
Table 89. CPC Scientific Peptide CDMO Product Offerings
Table 90. CPC Scientific Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 91. Peptide CDMO Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 92. Global Peptide CDMO Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Peptide CDMO Production by Region, 2017-2022 (Tons)
Table 94. Global Peptide CDMO Production by Region, 2023-2028 (Tons)
Table 95. Peptide CDMO Market Opportunities & Trends in Global Market
Table 96. Peptide CDMO Market Drivers in Global Market
Table 97. Peptide CDMO Market Restraints in Global Market
Table 98. Peptide CDMO Raw Materials
Table 99. Peptide CDMO Raw Materials Suppliers in Global Market
Table 100. Typical Peptide CDMO Downstream
Table 101. Peptide CDMO Downstream Clients in Global Market
Table 102. Peptide CDMO Distributors and Sales Agents in Global Market
Table 1. Key Players of Peptide CDMO in Global Market
Table 2. Top Peptide CDMO Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Peptide CDMO Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Peptide CDMO Revenue Share by Companies, 2017-2022
Table 5. Global Peptide CDMO Sales by Companies, (Tons), 2017-2022
Table 6. Global Peptide CDMO Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Peptide CDMO Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Peptide CDMO Product Type
Table 9. List of Global Tier 1 Peptide CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Peptide CDMO Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Peptide CDMO Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Peptide CDMO Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Peptide CDMO Sales (Tons), 2017-2022
Table 15. By Type - Global Peptide CDMO Sales (Tons), 2023-2028
Table 16. By Application – Global Peptide CDMO Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Peptide CDMO Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Peptide CDMO Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Peptide CDMO Sales (Tons), 2017-2022
Table 20. By Application - Global Peptide CDMO Sales (Tons), 2023-2028
Table 21. By Region – Global Peptide CDMO Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Peptide CDMO Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Peptide CDMO Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Peptide CDMO Sales (Tons), 2017-2022
Table 25. By Region - Global Peptide CDMO Sales (Tons), 2023-2028
Table 26. By Country - North America Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Peptide CDMO Sales, (Tons), 2017-2022
Table 29. By Country - North America Peptide CDMO Sales, (Tons), 2023-2028
Table 30. By Country - Europe Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Peptide CDMO Sales, (Tons), 2017-2022
Table 33. By Country - Europe Peptide CDMO Sales, (Tons), 2023-2028
Table 34. By Region - Asia Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Peptide CDMO Sales, (Tons), 2017-2022
Table 37. By Region - Asia Peptide CDMO Sales, (Tons), 2023-2028
Table 38. By Country - South America Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Peptide CDMO Sales, (Tons), 2017-2022
Table 41. By Country - South America Peptide CDMO Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Peptide CDMO Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Peptide CDMO Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Peptide CDMO Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Peptide CDMO Sales, (Tons), 2023-2028
Table 46. Bachem Corporate Summary
Table 47. Bachem Peptide CDMO Product Offerings
Table 48. Bachem Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. PolyPeptide Corporate Summary
Table 50. PolyPeptide Peptide CDMO Product Offerings
Table 51. PolyPeptide Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. AmbioPharm Corporate Summary
Table 53. AmbioPharm Peptide CDMO Product Offerings
Table 54. AmbioPharm Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. USV Peptides Corporate Summary
Table 56. USV Peptides Peptide CDMO Product Offerings
Table 57. USV Peptides Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Thermo Fisher Corporate Summary
Table 59. Thermo Fisher Peptide CDMO Product Offerings
Table 60. Thermo Fisher Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Bio Basic Corporate Summary
Table 62. Bio Basic Peptide CDMO Product Offerings
Table 63. Bio Basic Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. JPT Corporate Summary
Table 65. JPT Peptide CDMO Product Offerings
Table 66. JPT Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Genscript Corporate Summary
Table 68. Genscript Peptide CDMO Product Offerings
Table 69. Genscript Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Xinbang Pharma Corporate Summary
Table 71. Xinbang Pharma Peptide CDMO Product Offerings
Table 72. Xinbang Pharma Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. ScinoPharm Corporate Summary
Table 74. ScinoPharm Peptide CDMO Product Offerings
Table 75. ScinoPharm Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. SN Biopharm Corporate Summary
Table 77. SN Biopharm Peptide CDMO Product Offerings
Table 78. SN Biopharm Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 79. CBL Corporate Summary
Table 80. CBL Peptide CDMO Product Offerings
Table 81. CBL Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 82. Piramal Pharma Corporate Summary
Table 83. Piramal Pharma Peptide CDMO Product Offerings
Table 84. Piramal Pharma Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 85. CordenPharma Corporate Summary
Table 86. CordenPharma Peptide CDMO Product Offerings
Table 87. CordenPharma Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 88. CPC Scientific Corporate Summary
Table 89. CPC Scientific Peptide CDMO Product Offerings
Table 90. CPC Scientific Peptide CDMO Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 91. Peptide CDMO Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 92. Global Peptide CDMO Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Peptide CDMO Production by Region, 2017-2022 (Tons)
Table 94. Global Peptide CDMO Production by Region, 2023-2028 (Tons)
Table 95. Peptide CDMO Market Opportunities & Trends in Global Market
Table 96. Peptide CDMO Market Drivers in Global Market
Table 97. Peptide CDMO Market Restraints in Global Market
Table 98. Peptide CDMO Raw Materials
Table 99. Peptide CDMO Raw Materials Suppliers in Global Market
Table 100. Typical Peptide CDMO Downstream
Table 101. Peptide CDMO Downstream Clients in Global Market
Table 102. Peptide CDMO Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Peptide CDMO Segment by Type
Figure 2. Peptide CDMO Segment by Application
Figure 3. Global Peptide CDMO Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide CDMO Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide CDMO Revenue, 2017-2028 (US$, Mn)
Figure 7. Peptide CDMO Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Peptide CDMO Revenue in 2021
Figure 9. By Type - Global Peptide CDMO Sales Market Share, 2017-2028
Figure 10. By Type - Global Peptide CDMO Revenue Market Share, 2017-2028
Figure 11. By Type - Global Peptide CDMO Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Peptide CDMO Sales Market Share, 2017-2028
Figure 13. By Application - Global Peptide CDMO Revenue Market Share, 2017-2028
Figure 14. By Application - Global Peptide CDMO Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Peptide CDMO Sales Market Share, 2017-2028
Figure 16. By Region - Global Peptide CDMO Revenue Market Share, 2017-2028
Figure 17. By Country - North America Peptide CDMO Revenue Market Share, 2017-2028
Figure 18. By Country - North America Peptide CDMO Sales Market Share, 2017-2028
Figure 19. US Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Peptide CDMO Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Peptide CDMO Sales Market Share, 2017-2028
Figure 24. Germany Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 25. France Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Peptide CDMO Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Peptide CDMO Sales Market Share, 2017-2028
Figure 33. China Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 37. India Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Peptide CDMO Revenue Market Share, 2017-2028
Figure 39. By Country - South America Peptide CDMO Sales Market Share, 2017-2028
Figure 40. Brazil Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Peptide CDMO Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Peptide CDMO Sales Market Share, 2017-2028
Figure 44. Turkey Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 48. Global Peptide CDMO Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Peptide CDMO by Region, 2021 VS 2028
Figure 50. Peptide CDMO Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Peptide CDMO Segment by Type
Figure 2. Peptide CDMO Segment by Application
Figure 3. Global Peptide CDMO Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide CDMO Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide CDMO Revenue, 2017-2028 (US$, Mn)
Figure 7. Peptide CDMO Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Peptide CDMO Revenue in 2021
Figure 9. By Type - Global Peptide CDMO Sales Market Share, 2017-2028
Figure 10. By Type - Global Peptide CDMO Revenue Market Share, 2017-2028
Figure 11. By Type - Global Peptide CDMO Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Peptide CDMO Sales Market Share, 2017-2028
Figure 13. By Application - Global Peptide CDMO Revenue Market Share, 2017-2028
Figure 14. By Application - Global Peptide CDMO Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Peptide CDMO Sales Market Share, 2017-2028
Figure 16. By Region - Global Peptide CDMO Revenue Market Share, 2017-2028
Figure 17. By Country - North America Peptide CDMO Revenue Market Share, 2017-2028
Figure 18. By Country - North America Peptide CDMO Sales Market Share, 2017-2028
Figure 19. US Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Peptide CDMO Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Peptide CDMO Sales Market Share, 2017-2028
Figure 24. Germany Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 25. France Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Peptide CDMO Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Peptide CDMO Sales Market Share, 2017-2028
Figure 33. China Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 37. India Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Peptide CDMO Revenue Market Share, 2017-2028
Figure 39. By Country - South America Peptide CDMO Sales Market Share, 2017-2028
Figure 40. Brazil Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Peptide CDMO Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Peptide CDMO Sales Market Share, 2017-2028
Figure 44. Turkey Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Peptide CDMO Revenue, (US$, Mn), 2017-2028
Figure 48. Global Peptide CDMO Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Peptide CDMO by Region, 2021 VS 2028
Figure 50. Peptide CDMO Industry Value Chain
Figure 51. Marketing Channels
